Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.
Skip to main content

Table 8 The follow-up results

From: The feasibility of a dose painting procedure to treat prostate cancer based on mpMR images and hierarchical clustering

Parameters

Mean (range)

DP procedure

IMRT Procedure

Pre-radiotherapy

Post-radiotherapy

Percentage change

Pre-radiotherapy

Post-radiotherapy

Percentage change

DIL volume (cm3)

1.73 (0.1–4.9)

0.037 (0–0.4)

98.83 (78.9–100)

1.67 (0.04–5.1)

0.24 (0–1.2)

81.95 (38.89–100)

Whole prostate volume (cm3)

37.18 (21–56)

30.28 (18–46.9)

18.16 (4.16–51.35)

35.66 (20.77–62.37)

32.41 (18–53)

10.11 (2.4–26.32)

DIL ADC (10−6 mm2/s)

894.9 (572–1420)

1123 (823–1500)

32.18 (0.84–111.5)

884.3 (580–1462)

939.2 (698–1400)

10.35 (0.08–47.1)

Whole prostate ADC (10−6 mm2/s)

1122 (869–1389)

1072 (856–1325)

6.81 (1.44–15.85)

1154 (976–1421)

1059 (723–1312)

8.45 (1.41–20)

PSA level (ng/ml)

24.86 (13.3–45)

0.17 (.001–0.98)

99.2 (95–99.9)

22.22 (5.2–48)

0.15 (.002–0.8)

99 (93.4–100)

Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us